Report for: Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

Title	Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
Published by	Springer Nature, May 2020
DOI	10.1186/s13063-020-4202-x
Pubmed ID	32398113
Authors	Silvia Lanfranconi, Elisa Scola, Giulio Andrea Bertani, Barbara Zarino, Roberto Pallini, Giorgio d’Alessandris, Emanuela Mazzon, Silvia Marino, Maria Rita Carriero, Emma Scelzo, Giuseppe Faragò, Marco Castori, Carmela Fusco, Antonio Petracca, Leonardo d’Agruma, Laura Tassi, Piergiorgio d’Orio, Maria Grazia Lampugnani, Enrico Bjorn Nicolis, Antonella Vasamì, Deborah Novelli, Valter Torri, Jennifer Marie Theresia Anna Meessen, Rustam Al-Shahi Salman, Elisabetta Dejana, Roberto Latini

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United Kingdom	1	50%
United States	1	50%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	118	100%

Readers by professional status	Count	As %
Student > Bachelor	17	14%
Researcher	14	12%
Student > Master	10	8%
Student > Ph. D. Student	9	8%
Other	6	5%
Other	21	18%
Unknown	41	35%

Readers by discipline	Count	As %
Medicine and Dentistry	31	26%
Neuroscience	10	8%
Nursing and Health Professions	10	8%
Biochemistry, Genetics and Molecular Biology	6	5%
Unspecified	5	4%
Other	13	11%
Unknown	43	36%

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial